PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 46.71
+0.52 (1.13%)
At close: Feb 12, 2026
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 6.22 billion as of February 13, 2026. Its market cap has increased by 88.30% in one year.
Market Cap
6.22B
Enterprise Value
6.09B
Revenue
667.47M
Ranking
n/a
PE Ratio
176.74
Stock Price
46.71
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 6.22B, an increase of 57.89%. That is a compound annual growth rate of 14.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.22B | 51.36% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GemPharmatech | 7.15B |
| Jiangsu Aidea Pharmaceutical Group | 7.05B |
| Shenzhen Weiguang Biological Products | 7.00B |
| Shanghai OPM Biosciences | 6.92B |
| Beijing Konruns Pharmaceutical | 6.72B |
| Novogene | 6.34B |
| Xiangxue Pharmaceutical | 6.22B |
| Kexing Biopharm | 6.05B |